NASDAQ:OSUR
OraSure Technologies Stock News
$5.05
+0.150 (+3.06%)
At Close: May 22, 2024
OraSure Technologies (OSUR) Q1 Earnings Meet Estimates
07:20pm, Wednesday, 08'th May 2024
OraSure Technologies (OSUR) came out with quarterly earnings of $0.04 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.37 per share a year ago.
OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
08:00am, Monday, 22'nd Apr 2024
BETHLEHEM, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2024 financial results and certai
Wall Street Favorites: 3 Under-$10 Stocks With Strong Buy Ratings for April 2024
11:30am, Thursday, 18'th Apr 2024
Penny stocks are those that trade under $5. We'll call stocks that trade between $5 and $10 near-penny stocks.
NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board
08:31am, Thursday, 21'st Mar 2024
SPRINGDALE, Ark.--(BUSINESS WIRE)--NOWDiagnostics (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostics tests and first-in-class technology and platforms, today announced
OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript
10:16pm, Tuesday, 27'th Feb 2024
OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript
OraSure Reports Q4 ‘23 Revenue of $75.9 Million
04:05pm, Tuesday, 27'th Feb 2024
Q4 GAAP EPS of $0.27 ; Q4 Non-GAAP EPS of $0.22 Grew cash balance to $290.4 million as of December 31, 2023 E nters U.S. Syphilis testing market via strategic distribution agreement with Diagnostics
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
04:05pm, Tuesday, 13'th Feb 2024
BETHLEHEM, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2023 financial results and certai
3 Strong Buy Stocks Under $10: January 2024
06:42pm, Thursday, 01'st Feb 2024
Investors seeking strong buy stocks under $10 offering a potential future of large returns can be difficult. Inexpensive companies tend to have a small market cap and are typically riskier investments
Buy These 4 Low-Beta Stocks to Counter Market Volatility
08:41am, Thursday, 18'th Jan 2024
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Otter Tail (OTTR), Regeneron (REGN), OraSure (OSUR) and BioMarin Pharmaceutical (BMRN) are well-poised to ga
The relationship expands OraSure's innovation pipeline with access to a broad portfolio of key Sapphiros products in development.
After Golden Cross, OraSure Technologies (OSUR)'s Technical Outlook is Bright
11:17am, Monday, 27'th Nov 2023
After reaching an important support level, OraSure Technologies, Inc. (OSUR) could be a good stock pick from a technical perspective. OSUR recently experienced a "golden cross" event, which saw its 50
OraSure to Participate in Upcoming Investor Conferences
04:15pm, Monday, 13'th Nov 2023
BETHLEHEM, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
11:12am, Thursday, 09'th Nov 2023
If you're a fan of the hit TV show Shark Tank, you've probably come across the intriguing term “unicorn” companies. Indeed, these fantastical entities are not only confined to the realm of imagina
OraSure Technologies (OSUR) Tops Q3 Earnings and Revenue Estimates
08:17pm, Tuesday, 07'th Nov 2023
OraSure Technologies (OSUR) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.07 per share a year ago.
OraSure Technologies, Inc. (OSUR) Q3 2023 Earnings Call Transcript
07:20pm, Tuesday, 07'th Nov 2023
OraSure Technologies, Inc. (NASDAQ:OSUR ) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Jason Plagman - Vice President-Investor Relations Carrie Eglinton Manner - P